despit
substanti
declin
global
child
mortal
past
two
decad
six
million
children
die
annual
due
prevent
treatabl
ill
approxim
resourcelimit
set
africa
integr
manag
childhood
ill
imci
guidelin
develop
improv
clinic
manag
children
five
year
age
primari
health
care
worker
compris
simpl
algorithm
base
symptom
clinic
sign
lead
recommend
treatment
andor
manag
howev
scientif
base
behind
imci
gener
year
ago
sinc
profound
chang
epidemiolog
childhood
febril
ill
occur
mani
part
africa
follow
eg
introduct
new
vaccin
reduc
malaria
transmiss
use
malaria
rapid
diagnost
test
rdt
increas
antibiot
resist
therefor
necessari
reevalu
aetiolog
acut
uncompl
childhood
fever
also
assess
whether
imci
remain
reliabl
tool
identif
children
infect
presum
benefit
antibiot
treatment
complex
fever
aetiolog
highlight
applic
molecular
assay
detect
multipl
pathogen
frequent
detect
nucleic
acid
pathogen
among
patient
asymptomat
children
point
need
includ
healthi
control
fever
aetiolog
studi
howev
comprehens
studi
type
especi
africa
lack
therefor
studi
aetiolog
outcom
acut
uncompl
febril
ill
children
month
seek
care
primari
health
care
level
zanzibar
malaria
preelimin
set
subsaharan
africa
use
pointofcar
test
urin
cultur
confirmatori
chest
xray
cxr
investig
patient
imcipneumonia
classif
well
multiplex
quantit
q
pcr
investig
nasopharyng
nph
rectal
swab
patient
healthi
control
also
assess
util
imci
identif
infect
presum
requir
antibiot
prospect
descript
health
facil
base
studi
conduct
north
district
zanzibar
tanzania
apriljuli
follow
children
acut
uncompl
febril
ill
day
healthi
commun
control
group
recruit
comparison
studi
time
period
zanzibar
tropic
climat
season
rainfal
biannual
malaria
posit
rate
declin
dramat
past
decad
approxim
febril
patient
widescal
deploy
malaria
control
intervent
studi
district
mainli
rural
approxim
inhabit
public
health
care
deliv
primari
health
care
unit
one
primari
health
care
centr
kivung
addit
firstlevel
outpati
care
kivung
primari
health
care
centr
facil
basic
inpati
care
laboratori
servic
select
studi
site
base
central
locat
district
servic
presenc
research
laboratori
radiolog
equip
studi
staff
includ
clinician
clinic
offic
prescript
right
qualifi
nurs
laboratori
technician
clinician
train
imci
manag
particular
regard
integr
malaria
rdt
previous
describ
measur
respiratori
rate
children
present
studi
site
screen
elig
patient
enrol
daili
mondaysaturday
inclus
criteria
age
month
acut
uncompl
fever
defin
histori
fever
preced
hour
inform
caretak
andor
verifi
fever
axillari
temperatur
electron
thermomet
written
inform
proxi
consent
accompani
caretak
exclus
criteria
sign
sever
diseas
accord
imci
previou
studi
enrol
last
day
report
inabl
return
followup
data
document
structur
imcibas
questionnair
enrol
defin
day
studi
nurs
perform
malaria
rdt
studi
clinician
conduct
imci
assess
prescrib
treatment
follow
predefin
investig
includ
pointofcar
test
sampl
microbiolog
analys
cxr
perform
patient
other
patient
certain
clinic
featur
identifi
imci
manag
fig
particip
predefin
abnorm
laboratori
result
andor
sign
sever
diseas
discontinu
refer
clinic
manag
tabl
studi
investig
present
fig
fig
appendix
sampl
storag
perform
diagnost
done
accord
manufactur
instruct
studi
specif
standard
oper
procedur
investig
conduct
onsit
mnazi
mmoja
referr
hospit
remain
laboratori
analys
perform
sweden
franc
studi
complet
cxr
perform
interpret
accord
world
health
organ
standard
qualiti
control
read
done
sweden
patient
first
schedul
followup
day
four
day
second
day
day
evalu
fever
outcom
fig
caretak
instruct
return
children
case
sign
sever
diseas
occur
everi
followup
visit
studi
clinician
perform
clinic
reassess
includ
axillari
temperatur
child
return
schedul
followup
activ
trace
home
patient
symptomssign
sever
diseas
predefin
abnorm
laboratori
valu
withdraw
consent
followup
discontinu
studi
fig
healthi
control
hereaft
refer
control
defin
children
age
month
histori
diarrhoea
cough
run
nose
fever
histori
andor
electron
axillari
temperatur
preced
ten
day
recruit
studi
time
period
recruit
aim
repres
distribut
age
sex
geographi
base
previou
health
facil
data
eight
villag
catchment
area
high
attend
studi
primari
health
care
centr
identifi
studi
week
one
eight
villag
visit
asymptomat
children
identifi
housetohous
screen
elig
children
maximum
two
per
household
provid
nph
rectal
swab
qpcranalys
fig
criteria
respect
final
diagnos
defin
two
studi
investig
paediatrician
base
avail
clinic
radiologylaboratori
data
day
tabl
fig
includ
multipl
regress
analysi
qpcr
result
describ
appendix
subsequ
criteria
appli
patient
diagnos
categor
three
group
probabl
caus
fever
less
probabl
caus
fever
verifi
aetiolog
probabl
diagnosi
identifi
less
probabl
diagnos
ignor
patient
within
one
group
patient
could
receiv
one
diagnosi
studi
definit
outlin
tabl
infect
requir
antibiot
defin
retrospect
final
diagnos
presum
benefit
antibiot
base
recommend
associ
infect
actual
prescrib
antibiot
imci
indic
antibiot
assess
exploratori
studi
preclud
sampl
size
calcul
howev
estim
sampl
patient
would
suffici
obtain
repres
classif
fever
caus
accord
imci
least
control
would
requir
make
comparison
microbiolog
find
obtain
pcr
analysi
nasopharyng
rectal
specimen
data
doubl
enter
cspro
valid
export
statist
analys
perform
frequenc
proport
odd
ratio
or
calcul
confid
interv
ci
pvalu
consid
statist
signific
fisher
exact
test
exact
binomi
test
use
binari
data
proport
twosampl
ttest
comparison
mean
mannwhitneyu
test
median
comparison
univari
multivari
logist
regress
assess
associ
cxrconfirm
pneumonia
continu
binari
variabl
outlin
tabl
wbc
crp
cutoff
valu
mgl
chosen
concur
publish
literatur
studi
conduct
accord
declar
helsinki
approv
zanzibar
medic
research
ethic
committe
id
region
research
ethic
committe
stockholm
gothenburg
sweden
written
inform
proxi
consent
accompani
caretak
obtain
subsequ
record
consent
form
patient
well
healthi
control
recruit
studi
assist
medic
offic
ensur
laboratori
result
requir
medic
intervent
tabl
andor
referr
manag
accordingli
clinic
manag
treatment
referr
provid
free
charg
studi
particip
particip
receiv
financi
incent
except
travel
expens
patient
studi
registr
clinicaltrialsorg
done
data
acquisit
baselin
characterist
patient
control
present
tabl
fortytwo
percent
patient
verifi
fever
enrol
patient
classifi
accord
imci
fig
one
imci
classif
assign
patient
patient
complet
followup
visit
fig
remain
febril
first
followup
visit
verifi
fever
day
addit
children
verifi
fever
relaps
second
followup
visit
total
analys
conduct
detect
pathogen
crude
qpcr
detect
rate
nasopharyng
pathogen
patient
healthi
control
well
comparison
ct
valu
group
present
fig
tabl
nph
qpcr
detect
one
pathogen
patient
median
pathogen
rang
control
median
pathogen
rang
significantli
higher
detect
rate
found
patient
control
enteroviru
influenza
influenza
b
rsv
p
appendix
file
tabl
multipl
pathogen
detect
patient
control
previous
report
rectal
swab
qpcr
detect
least
one
diarrheal
ge
pathogen
patient
diarrhoea
median
pathogen
rang
control
median
pathogen
rang
fig
multipl
pathogen
detect
geqpcr
patient
control
significantli
higher
detect
rate
patient
control
seen
cryptosporidium
noroviru
genogroup
ii
rotaviru
shigella
etecesta
also
identifi
caus
gastroenter
significantli
higher
pathogen
load
faec
patient
compar
control
fig
show
urin
cultur
pointofcar
blood
test
result
perform
exclus
patient
two
patient
plasmodium
falciparum
detect
rdt
microscopi
pcr
specimen
subject
pcranalys
addit
blood
pathogen
rickettsiosi
chikungunya
dengu
rift
valley
fever
west
nile
virus
neg
microbiolog
result
pointofcar
urin
cultur
pcr
pool
fig
median
three
pathogen
rang
observ
per
patient
eight
patient
detect
pathogen
patient
imcipneumonia
classif
underw
cxr
confirm
pneumonia
patient
suffici
cxr
qualiti
univari
multivari
regress
analysi
determin
crp
independ
variabl
significantli
associ
cxrconfirm
pneumonia
tabl
crplevel
correspond
ci
p
nphqpcr
detect
pneumococci
rsv
influenza
b
enteroviru
patient
cxrconfirm
pneumonia
total
patient
assign
final
diagnosi
fig
includ
multipl
diagnos
result
diagnos
total
common
diagnos
viral
respiratori
tract
infect
caus
rsv
influenza
b
rhinoviru
enteroviru
influenza
wherea
common
bacteri
infect
group
streptococci
ga
cxrconfirm
pneumonia
shigella
gastroenter
fig
fig
two
deceas
children
seven
develop
sign
sever
ill
enrol
fig
assign
influenza
enteroviru
final
diagnos
receiv
antibiot
enrol
remain
five
children
coronaviru
rhinoviru
infect
n
bocaviru
ga
infect
influenza
respect
neither
differ
earli
fever
resolut
tabl
among
patient
without
seriou
bacteri
infect
cxrconfirm
pneumonia
andor
urinari
tract
infect
tabl
among
patient
treat
treat
antibiot
p
enrol
patient
prescrib
antibiot
receiv
beta
lactam
tabl
among
patient
infect
requir
antibiot
fig
receiv
antibiot
common
gasinfect
cxrconfirm
pneumonia
remain
prescrib
antibiot
recov
although
one
episod
convuls
followup
among
patient
without
infect
requir
antibiot
fig
imci
indic
antibiot
major
due
imcipneumonia
convers
patient
infect
requir
antibiot
imci
indic
antibiot
yet
receiv
treatment
knowledg
first
aetiolog
studi
nonsever
fever
african
children
appli
comprehens
laboratori
panel
includ
healthi
control
group
viral
respiratori
tract
infect
identifi
common
fever
caus
vast
major
patient
least
one
detect
pathogen
howev
agent
qualifi
causal
aetiolog
eg
pneumococci
nphqpcr
patient
could
assign
final
diagnosi
result
multipl
pathogen
detect
larg
proport
specimen
patient
control
underlin
complex
childhood
infect
also
mani
pathogen
detect
similar
frequenc
patient
control
previous
observ
emphas
need
incorpor
control
studi
caus
fever
compar
qpcr
ctvalu
addit
crude
posit
rate
proxi
pathogen
load
patient
control
appli
multipl
regress
analysi
control
confound
factor
identif
caus
agent
like
improv
studi
appendix
tabl
tabl
b
file
similar
approach
aetiolog
identif
previous
use
gastrointestin
well
nasopharyng
pathogen
overal
nphqpcr
result
coher
previou
studi
acut
respiratori
tract
infect
african
preschool
children
howev
observ
studi
enteroviru
common
fever
caus
novel
call
confirmatori
studi
like
studi
distinguish
enteroviru
rhinoviru
detect
strength
studi
base
clinic
microbiolog
data
retrospect
assign
individu
final
patient
diagnos
allow
assess
whether
antibiot
prescrib
presum
benefit
treatment
imci
manag
previous
shown
reduc
inappropri
antibiot
prescript
comparison
standard
fever
case
manag
major
antibioticrequir
infect
studi
inde
treat
antibiot
still
imci
manag
result
substanti
overprescript
antibiot
comparison
final
fever
diagnos
retriev
base
avail
clinic
laboratori
data
correspond
antibiot
requir
thu
among
patient
fulfil
imcipneumonia
classif
cxrconfirm
pneumonia
similar
result
report
other
hospit
children
nonsever
imcipneumonia
indic
imcipneumonia
classif
base
presenc
cough
rapid
breath
low
precis
identifi
lower
antibiot
requir
respiratori
tract
infect
imcipneumonia
classif
largest
contributor
presum
unnecessari
antibiot
prescript
studi
multipl
logist
regress
analysi
crp
posit
predictor
cxrconfirm
pneumonia
howev
approxim
cxrconfirm
pneumonia
studi
crp
mgl
viral
pathogen
detect
nphqpcr
suggest
cxrconfirm
pneumonia
might
viral
origin
imci
guidelin
remain
quit
similar
sinc
introduct
except
recent
integr
malaria
rdt
proven
use
zanzibar
imci
combin
crp
andor
biomark
could
play
similar
role
reliabl
confirm
exclud
bacteri
infect
like
pneumonia
need
studi
plan
studi
infect
requir
antibiot
follow
issu
address
sever
andor
nonsever
ill
patient
includ
ill
identifi
eg
pointofcar
versu
molecular
base
diagnost
techniqu
likelihood
find
singl
laboratori
testbiomark
near
futur
could
distinguish
infect
presum
requir
antibiot
infect
low
instanc
fig
show
gasinfect
shigellosi
main
infect
requir
antibiot
imci
algorithm
identifi
henc
way
forward
would
probabl
complex
stepwis
approach
combin
clinic
sign
multipl
biomark
point
care
detect
pathogen
overal
health
outcom
satisfactori
rel
children
develop
sever
diseas
followup
one
reason
might
abil
clinician
identifi
danger
sign
enrol
result
concur
previou
studi
imci
manag
uncompl
childhood
fever
first
referr
level
pakistan
papua
new
guinea
also
report
differ
outcom
children
treat
treat
antibiot
similar
distribut
fever
caus
observ
studi
predomin
viral
infect
seriou
bacteri
infect
studi
report
highincom
countri
due
differ
methodolog
inclus
criteria
difficult
compar
find
previou
studi
fever
aetiolog
african
children
recent
studi
tanzania
also
appli
broad
microbiolog
test
panel
report
viral
infect
common
fever
caus
howev
import
methodolog
differ
dacremont
et
al
studi
includ
older
children
importantli
includ
control
group
asymptomat
children
studi
sever
limit
firstli
conduct
time
period
directli
follow
main
raini
season
zanzibar
respiratori
tract
infect
known
frequent
diarrheal
infect
like
rotaviru
less
frequent
might
therefor
repres
infect
occur
whole
year
secondli
control
sampl
nasopharyng
rectal
swab
lack
control
test
might
exampl
result
overestim
ga
infect
thirdli
chose
includ
blood
cultur
due
assum
low
yield
bacteraemia
focu
acut
uncompl
fever
preclud
conclus
regard
frequenc
outcom
sever
infect
conclus
studi
aetiolog
antibiot
treatment
outcom
nonsever
febril
childhood
ill
malaria
preelimin
set
africa
first
use
comprehens
laboratori
panel
includ
healthi
control
group
show
complex
determin
infecti
aetiolog
major
fever
caus
viral
upper
respiratori
tract
infect
similarli
children
highincom
countri
major
asymptomat
children
potenti
pathogen
detect
nphqpcr
often
similar
proport
patient
underlin
need
includ
control
precis
imci
identifi
infect
presum
requir
antibiot
low
